Int J Biol Sci 2022; 18(10):3942. doi:10.7150/ijbs.75583 This issue Cite

Retraction

miR-1204 promotes hepatocellular carcinoma progression through activating MAPK and c-Jun/AP1 signaling by targeting ZNF418 : Retraction

Liang Wang, Liankang Sun, Yufeng Wang, Bowen Yao, Runkun Liu, Tianxiang Chen, Kangsheng Tu, Qingguang Liu, Zhikui Liu

Department of Hepatobiliary Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China, 710061.

Citation:
Wang L, Sun L, Wang Y, Yao B, Liu R, Chen T, Tu K, Liu Q, Liu Z. miR-1204 promotes hepatocellular carcinoma progression through activating MAPK and c-Jun/AP1 signaling by targeting ZNF418 : Retraction. Int J Biol Sci 2022; 18(10):3942. doi:10.7150/ijbs.75583. https://www.ijbs.com/v18p3942.htm
Other styles

File import instruction

Retracted-article in Int J Biol Sci, Volume 15, 1514


Citation styles

APA
Wang, L., Sun, L., Wang, Y., Yao, B., Liu, R., Chen, T., Tu, K., Liu, Q., Liu, Z. (2022). miR-1204 promotes hepatocellular carcinoma progression through activating MAPK and c-Jun/AP1 signaling by targeting ZNF418 : Retraction. International Journal of Biological Sciences, 18(10), 3942. https://doi.org/10.7150/ijbs.75583.

ACS
Wang, L.; Sun, L.; Wang, Y.; Yao, B.; Liu, R.; Chen, T.; Tu, K.; Liu, Q.; Liu, Z. miR-1204 promotes hepatocellular carcinoma progression through activating MAPK and c-Jun/AP1 signaling by targeting ZNF418 : Retraction. Int. J. Biol. Sci. 2022, 18 (10), 3942. DOI: 10.7150/ijbs.75583.

NLM
Wang L, Sun L, Wang Y, Yao B, Liu R, Chen T, Tu K, Liu Q, Liu Z. miR-1204 promotes hepatocellular carcinoma progression through activating MAPK and c-Jun/AP1 signaling by targeting ZNF418 : Retraction. Int J Biol Sci 2022; 18(10):3942. doi:10.7150/ijbs.75583. https://www.ijbs.com/v18p3942.htm

CSE
Wang L, Sun L, Wang Y, Yao B, Liu R, Chen T, Tu K, Liu Q, Liu Z. 2022. miR-1204 promotes hepatocellular carcinoma progression through activating MAPK and c-Jun/AP1 signaling by targeting ZNF418 : Retraction. Int J Biol Sci. 18(10):3942.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.